Once daily, oral investigational therapy reduced sustained Moderate vision loss by 40% over three-year period for patients with moderate to severe non-proliferative diabetic retinopathy.

While exercise and weight loss are equally effective ways to lose weight, exercising helps to maintain muscles, research finds.

Studies of a rare genetic condition that increases cancer risk have unveiled a potential treatment for metabolic syndrome, and diabetes disorders that afflicts as many as one in every four American adults and puts them at sharply increased risk cardiovascular disease, heart attacks and strokes.

New study shows that you can eat bread and lose weight?? Bread enriched with lupin kernel flour at the expense of wheat flour reduced energy intake and increased the feeling of fullness, which may have important implications for weight management.

Acording to a report in the November issue of Diabetes Care, Alpha-lipoic acid (ALA) given orally improves symptoms in patients with diabetic polyneuropathy.

This is the first study ever to evaluate WelChol in combination with insulin, and it demonstrated A1C reductions of 0.5%.

A U.S. decision on approving Novartis AG’s key diabetes drug Galvus has been delayed by three months after the firm asked the Food and Drug Administration to consider new clinical trials data.

Fasting glucose (FG) levels increase in older adults with hypertension regardless of whether they are treated with chlorthalidone, amlodipine, or lisinopril.

With one in two having diabetes, it could wipe out Maori and Polynesian Islanders by the end of the century, according to an international expert in the disease.

Accomplia is now approved in Europe and Mexico, US next?